<DOC>
	<DOCNO>NCT02941913</DOCNO>
	<brief_summary>BACKGROUND : Palonosetron second generation serotonin antagonist usually use ﬁxed dose 75 mcg prophylaxis postoperative nausea vomit . Although trial evaluate bodyweight-adjusted dos palonosetron , ideal dose obese patient yet investigate . The aim study evaluate use bodyweight-adjusted dos palonosetron ( 1mcg / kg ) effective fix dose ( 75mcg ) prevent postoperative nausea vomit female patient body mass index equal 30 kg /m2 undergone breast surgery METHODS : A prospective , randomized double-blind trial conduct National Cancer Institute ( INCA - HCIII ) , Rio de Janeiro , Brazil . Eligible patient female age 18-70 year age ASA physical status one three , body mass index equal great 30 kg / m2 , schedule undergo elective breast surgery . Forty patient randomized receive fix dose 75 μg palonosetron ( group I - GI ) 40 patient receive bodyweight-adjusted dose 1mcg/kg palonosetron ( group II - GII ) . Patients assess 3 time period : 0-6 h , 6-26 h 24-48 h surgery . After discharge , patient contact telephone regular interval record episodes nausea vomit well analgesic antiemetic requirement . The primary outcome measure include number emetic episode , incidence nausea , need rescue antiemetic analgesic requirement 48h . The secondary outcome evaluate frequency polymorphism 5-HT3 receptor correlation antiemetic effect adverse effect .</brief_summary>
	<brief_title>Compare Between Two Doses Palonosetron Prevention Postoperative Nausea Vomiting Obese Patients</brief_title>
	<detailed_description>Prevention nausea vomit surgery routine throughout anesthetic-surgical procedure , since discomfort morbidity associate anesthetic complication widely know . The serotonin antagonists largely use purpose exhibit superior prophylactic efficacy compare antiemetic drug . Its mechanism action inhibition calcium influx cause stimulation serotonin 5-hydroxytryptamine type 3 receptor ( 5-HT3 ) . Palonosetron second generation serotonin antagonist high affinity bind 5-HT3 receptor . It unique chemical structure longer half-life old 5-HT3 antagonist . It initially approve use prevention chemotherapy induce nausea vomit also prove effective prophylaxis postoperative nausea vomiting . Palonosetron usually use ﬁxed dose 75 mcg prophylaxis postoperative nausea vomit . Although trial evaluate bodyweight-adjusted dos palonosetron , ideal dose obese patient yet investigate . Aims &amp; Objectives : The hypothesis study use bodyweight-adjusted dos palonosetron ( 1mcg / kg ) effective fix dose ( 75mcg ) prevent postoperative nausea vomit female patient body mass index equal 30 kg / m2 undergone breast surgery . Methods : A prospective , randomized double-blind trial conduct National Cancer Institute ( INCA - HCIII ) , Rio de Janeiro , Brazil . All patient provide write informed consent form prior study enrolment . Using computer-generated random number , patient assign one two treatment group morning surgery . Forty patient randomized receive fix dose 75 μg palonosetron ( group I - fix dose group ) another forty patient receive bodyweight-adjusted dose 1mcg/kg palonosetron ( group II - bodyweight-adjusted group ) . Each study drug mixed saline total volume 10 ml unlabelled syringe intravenously administer prior induction anesthesia . All patient , surgeon , anesthesiologist involve study blind group allocation maintain double-blind condition . All patient receive premedication midazolam . Intraoperative monitoring include electrocardiography , blood pressure measurement , peripheral oxygen saturation ( SpO2 ) , end-tidal CO2 tension ( ETco2 ) . General anesthesia induce use 1,5 mg/kg propofol , 3 μg/kg fentanyl , 1,5 mg/kg lidocaine 0.3 mg/kg rocuronium . Then insertion laryngeal mask perform pulmonary ventilation maintain 6 ml/kg ideal-weight maximum peak pressure 25 cmH2O . The anesthesia maintain sevoflurane 50 % oxygen/air . Sevoflurane concentration adjust ensure equal depth anesthesia surgery assess bispectral index ( BIS ; BIS A-1050 Monitor , Aspect Medical Systems , Newton , MA , USA ) , hold 40-60 . Remifentanil administer supplemental intraoperative analgesia dose adjust maintain blood pressure heart rate within 20 % baseline value . At end surgery , residual neuromuscular blockade reverse 2mg/kg Sugammadex laryngeal mask remove . Patients stay postanesthetic care unit least 1 hour go ward . In postoperative recovery room , haemodynamic variable along postoperative complication shiver , hypotension , dizziness , constipation adverse reaction drug record blind observer . After surgery , rescue medication intravenous metoclopramide ( 10 mg ) one episodes nausea vomit . All episode nausea vomit record 48h . Patients assess 3 time period : 0-6 h , 6-26 h 24-48 h surgery . After discharge , patient contact telephone regular interval record episodes nausea vomit well analgesic antiemetic requirement . The primary outcome measure include number emetic episode , incidence nausea , need rescue antiemetic analgesic requirement 48h . Nausea deﬁned subjective unpleasant sensation associate urge vomit without expulsion gastric content vomit deﬁned forceful expulsion gastric content trough mouth . The secondary outcome evaluate frequency polymorphism 5-HT3 receptor correlation antiemetic effect adverse effect . The patient cell sample oral cavity , collect smear . The collected material place tube store freezer . Then , analyze laboratory Clinical Research Unit Federal Fluminense University ( UFF ) . After extract DNA sample use DNA purification kit , polymerase chain reaction ( PCR ) perform analysis single nucleotide polymorphism . Biological sample discard end analysis . Sample size calculate reference result study compare weight-adjusted dos palonosetron prevention PONV laparoscopic gynaecological surgery no-obese patient . For P value 0.05 power 0.8 , minimum 36 per dose group require . To allow possible dropout , aim recruit 40 patient group . SPSS version 13.0 ( SPSS Inc , Chicago , IL , USA ) use statistical analysis . The Shapiro-Wilk test use ensure data normally distribute . Patient characteristic intra- post-operative variable analyse two-tailed ANOVA . For nonparametric variable , Kruskal-Wallis test apply . Proportions compare use x2 square Fisher 's exact test . The dose-dependency effect palonosetron assess use x2 trend test proportion . A P value &lt; 0.05 consider statistically significant .</detailed_description>
	<mesh_term>Nausea</mesh_term>
	<mesh_term>Vomiting</mesh_term>
	<mesh_term>Postoperative Nausea Vomiting</mesh_term>
	<mesh_term>Palonosetron</mesh_term>
	<criteria>female age 1870 year ASA physical status one three body mass index equal great 30 kg / m2 schedule undergo elective breast surgery patient receive chemotherapy within 4 week , patient undergone emergency surgery , history vomit within 24 hour ; hypersensitivity 5HTantagonists , patient receive antiemetic , corticosteroid , drug antiemetic effect , smoker history alcoholism .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>